|Source:||The roots of Panax ginseng C. A. Mey.|
|Biological Activity or Inhibitors:|| 1. 20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
|Solvent:||Pyridine, Methanol, Ethanol, etc.|
|Storage:||Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: email@example.com
|After receiving:||The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.|
|1 mg||5 mg||10 mg||20 mg||25 mg|
|1 mM||1.5652 mL||7.826 mL||15.6519 mL||31.3038 mL||39.1298 mL|
|5 mM||0.313 mL||1.5652 mL||3.1304 mL||6.2608 mL||7.826 mL|
|10 mM||0.1565 mL||0.7826 mL||1.5652 mL||3.1304 mL||3.913 mL|
|50 mM||0.0313 mL||0.1565 mL||0.313 mL||0.6261 mL||0.7826 mL|
|100 mM||0.0157 mL||0.0783 mL||0.1565 mL||0.313 mL||0.3913 mL|
Zhongguo Zhong Yao Za Zhi. 2013 Nov;38(22):3910-7.
|Chemical constituents from processed rhizomes of Panax notoginseng.[Pubmed: 24558875]|
|On the basis of physicochemical properties and spectral data analysis, their structures were identified to be 6'-O-Acetylginsenoside Rh1 (1), ginsenoside RK3 (2), ginsenoside Rh4 (3), 20S-ginsenoside Rg3 (4), ginsenoside Rk1 (5), 20R-ginsenoside Rg3 (6), ginsenoside Rg5 (7), ginsenoside F2 (8), 20S-ginsenoside Rh1 (9), (20R)-Ginsenoside Rh1 (10), gypenoside X VII (11), notoginsenoside Fa, (12), ginsenoside Ra3 (13), ginsenoside Rg1 (14), ginsenoside Re (15), notoginsenoside R2 (16), ginsenoside Rg2 (17), notoginsenoside R1 (18), ginsenoside Rd (19), ginsenoside Rb1 (20), notoginsenoside D (21), notoginsenoside R4 (22) and ginsenoside Rb2 (23), respectively.|
Japanese Journal of Pharmacognosy, 1985, 39:123-5.
|Pharmacological Study on Panax ginseng C.A. MEYER V. : Effects of Red Ginseng on the Experimental Disseminated Intravascular Coagulation (4). On Ginsenoside-Rg3, Rh1 and Rh2[Reference: WebLink]|
|20S, 20R ginsenoside-Rg3, 20S, 20R ginsenoside-Rh1 and ginsenoside-Rh2 isolated from Red Ginseng were investigated for their effect on blood platelet aggregation and thrombin-induced conversion of fibrinogen to fibrin in vitro. 20S, 20R ginsenoside-Rg3 inhibited collagen- and ADP-induced blood platelet aggregation. 20S ginsenoside-Rg3, 20S, 20R ginsenoside-Rh1 inhibited the thrombin-induced conversion of fibrinogen to fibrin.|